About PROVECTUS BIOPHARMACEUTICALS INC
Provectus Biopharmaceuticals, Inc. is a clinical-stage biotechnology company developing immunotherapy medicines based on small molecules called halogenated xanthenes, with a focus on making innovative medicines equitably accessible and financially affordable globally.
Development of immunotherapy medicines based on halogenated xanthenesClinical and non-clinical research across multiple disease areas including oncology, dermatology, hematology, virology, microbiology, and ophthalmology
Is this your company?
Claim PROVECTUS BIOPHARMACEUTICALS INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim PROVECTUS BIOPHARMACEUTICALS INC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.